Results from a large study show that, for most people with advanced bladder cancer, starting immunotherapy with avelumab (Bavencio) shortly after initial treatment with chemotherapy is better than delaying treatment.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/3exUaB1
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/3exUaB1